These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Bronchospasm precipitated by ophthalmic instillations of timolol. Lockey SD Ann Allergy; 1981 May; 46(5):267. PubMed ID: 7235319 [No Abstract] [Full Text] [Related]
24. Beta-receptor blockade following the use of eye drops. Samuels SI; Maze M Anesthesiology; 1980 Apr; 52(4):369-70. PubMed ID: 7362061 [No Abstract] [Full Text] [Related]
25. Eye drops and lethargy. Vahidassr MD; Foy CJ; O'Malley T; Passmore AP J R Soc Med; 1997 Mar; 90(3):155. PubMed ID: 9135614 [No Abstract] [Full Text] [Related]
27. [Long-term treatment of chronic glaucoma with timolol drops: results after four years (author's transl)]. Plane C; Boulmier A J Fr Ophtalmol; 1981; 4(11):751-6. PubMed ID: 7328270 [TBL] [Abstract][Full Text] [Related]
28. Potential side effects of timolol therapy in the treatment of glaucoma. Zimmerman TJ; Leader BJ; Golob DS Ann Ophthalmol; 1981 Jun; 13(6):683-9. PubMed ID: 7020551 [TBL] [Abstract][Full Text] [Related]
30. [Systemic side effects of topical timolol]. Nissimov R Harefuah; 1980 Dec; 99(11):376-8. PubMed ID: 7297950 [No Abstract] [Full Text] [Related]
31. [Systemic adverse affects of beta-blocking agents used in local treatment of the eye]. Laake K Tidsskr Nor Laegeforen; 1980 Mar; 100(7):453. PubMed ID: 7385201 [No Abstract] [Full Text] [Related]
32. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients]. Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254 [TBL] [Abstract][Full Text] [Related]
34. Latanoprost: new preparation. Antiglaucoma eye drops that can change the colour of the iris. Prescrire Int; 1998 Dec; 7(38):166-8. PubMed ID: 10848045 [TBL] [Abstract][Full Text] [Related]
36. [Supplementary note on the use of timolol in asthmatics]. Corbel M Bull Soc Ophtalmol Fr; 1982 Feb; 82(2):235-6. PubMed ID: 7105338 [No Abstract] [Full Text] [Related]
37. [Complete atrioventricular block secondary to application of timolol eyedrops: importance of the preanesthetic interview]. Sánchez-Conde P; Nicolás BJ; Rodríguez LJ Rev Esp Anestesiol Reanim; 2005; 52(7):438-40. PubMed ID: 16200927 [No Abstract] [Full Text] [Related]
38. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. Flórez A; Rosón E; Conde A; González B; García-Doval I; de la Torre C; Cruces M J Am Acad Dermatol; 2005 Nov; 53(5):909-11. PubMed ID: 16243161 [No Abstract] [Full Text] [Related]
39. [Local application of timolol is not a panacea in the management of glaucoma. Examples]. Béchetoille A Bull Soc Ophtalmol Fr; 1980 Jan; 80(1):79-83. PubMed ID: 7226377 [No Abstract] [Full Text] [Related]
40. Major depressive episode secondary to antiglaucoma drugs. Kurtz S; Ashkenazi I; Melamed S Am J Psychiatry; 1993 Mar; 150(3):524-5. PubMed ID: 8434677 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]